Home Blood Pressure Stability Score is Associated with Better Cardiovascular Prognosis: Data from the Nationwide Prospective J-HOP Study

Overview

Journal Hypertens Res

Specialty Cardiology & Vascular Diseases

Date 2024 Oct 11

PMID 39394518

Authors

Kazuomi Kario

Hiroshi Kanegae

Satoshi Hoshide

Affiliations

Soon will be listed here.

Abstract

A home blood pressure (BP)-centered strategy is emerging as the optimal approach to achieve adequate BP control in individuals with hypertension, but a simple cardiovascular risk score based on home BP level and variability is lacking. This study used prospective data from the Japan Morning Surge-Home Blood Pressure (J-HOP) extended study to develop a simple home BP stability score for the prediction of cardiovascular risk. The J-HOP extended study included 4070 participants (mean age 64.9 years) who measured home BP three times in the morning and evening for 14 days at baseline. During the mean 6.3-year follow-up, there were 260 cardiovascular events. A home BP stability score was calculated based on the average of morning and evening systolic BP (SBP; MEave), and three home BP variability metrics: average real variability (average absolute difference between successive measurements); average peak (average of the highest three SBP values for each individual), and time in therapeutic range (proportion of time spent with MEave home SBP 100-135 mmHg). There was a curvilinear association between the home BP stability score and the risk of cardiovascular events. Compared with individuals in the optimal home SBP stability score group (9-10 points), those in the very high-risk group (0 points) had significantly higher cardiovascular event risk during follow-up (adjusted hazard ratio 3.97, 95% confidence interval 2.22-7.09; p < 0.001), independent of age, sex, medication, cardiovascular risk factors, and office BP. These data show the potential for a simple home BP-based score to predict cardiovascular event risk in people with hypertension.

References

Asayama K, Stolarz-Skrzypek K, Yang W, Hansen T, Brguljan-Hitij J, Odili A . What did we learn from the International Databases on Ambulatory and Home Blood Pressure in Relation to Cardiovascular Outcome?. Hypertens Res. 2023; 46(4):934-949. PMC: 10073019. DOI: 10.1038/s41440-023-01191-4. View

Ihm S, Park J, Kim J, Kim J, Kim K, Lee E . Home blood pressure monitoring: a position statement from the Korean Society of Hypertension Home Blood Pressure Forum. Clin Hypertens. 2022; 28(1):38. PMC: 9526300. DOI: 10.1186/s40885-022-00218-1. View

Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A . 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal.... J Hypertens. 2023; 41(12):1874-2071. DOI: 10.1097/HJH.0000000000003480. View

Parati G, Stergiou G, Bilo G, Kollias A, Pengo M, Ochoa J . Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension. J Hypertens. 2021; 39(9):1742-1767. PMC: 9904446. DOI: 10.1097/HJH.0000000000002922. View

Park S, Buranakitjaroen P, Chen C, Chia Y, Divinagracia R, Hoshide S . Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia Network. J Hum Hypertens. 2018; 32(4):249-258. DOI: 10.1038/s41371-017-0025-y. View

Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y . The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019; 42(9):1235-1481. DOI: 10.1038/s41440-019-0284-9. View

Wang T, Chiang C, Chao T, Cheng H, Wu Y, Wu Y . 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension. Acta Cardiol Sin. 2022; 38(3):225-325. PMC: 9121756. DOI: 10.6515/ACS.202205_38(3).20220321A. View

Whelton P, Carey R, Aronow W, Casey Jr D, Collins K, Himmelfarb C . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association.... Hypertension. 2017; 71(6):1269-1324. DOI: 10.1161/HYP.0000000000000066. View

Kario K . Digital hypertension towards to the anticipation medicine. Hypertens Res. 2023; 46(11):2503-2512. DOI: 10.1038/s41440-023-01409-5. View

10.

Kario K, Tomitani N, Wang T, Park S, Li Y, Shin J . Home blood pressure-centered approach - from digital health to medical practice: HOPE Asia Network consensus statement 2023. Hypertens Res. 2023; 46(12):2561-2574. DOI: 10.1038/s41440-023-01397-6. View

11.

Parati G, Dolan E, McManus R, Omboni S . Home blood pressure telemonitoring in the 21st century. J Clin Hypertens (Greenwich). 2018; 20(7):1128-1132. PMC: 8030819. DOI: 10.1111/jch.13305. View

12.

Parati G, Bilo G, Kollias A, Pengo M, Ochoa J, Castiglioni P . Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper ∗. J Hypertens. 2023; 41(4):527-544. DOI: 10.1097/HJH.0000000000003363. View

13.

Parati G, Stergiou G, Dolan E, Bilo G . Blood pressure variability: clinical relevance and application. J Clin Hypertens (Greenwich). 2018; 20(7):1133-1137. PMC: 8030809. DOI: 10.1111/jch.13304. View

14.

Arima H, Yonemoto K, Doi Y, Ninomiya T, Hata J, Tanizaki Y . Development and validation of a cardiovascular risk prediction model for Japanese: the Hisayama study. Hypertens Res. 2009; 32(12):1119-22. DOI: 10.1038/hr.2009.161. View

15.

Goff Jr D, Lloyd-Jones D, Bennett G, Coady S, DAgostino R, Gibbons R . 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 129(25 Suppl 2):S49-73. DOI: 10.1161/01.cir.0000437741.48606.98. View

16.

Hajifathalian K, Ueda P, Lu Y, Woodward M, Ahmadvand A, Aguilar-Salinas C . A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol. 2015; 3(5):339-55. PMC: 7615120. DOI: 10.1016/S2213-8587(15)00081-9. View

17.

Hippisley-Cox J, Coupland C, Brindle P . Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017; 357:j2099. PMC: 5441081. DOI: 10.1136/bmj.j2099. View

18.

Honda T, Yoshida D, Hata J, Hirakawa Y, Ishida Y, Shibata M . Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: The Hisayama Study. Atherosclerosis. 2018; 279:38-44. DOI: 10.1016/j.atherosclerosis.2018.10.014. View

19.

Hoshide S, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S . Morning and Evening Home Blood Pressure and Risks of Incident Stroke and Coronary Artery Disease in the Japanese General Practice Population: The Japan Morning Surge-Home Blood Pressure Study. Hypertension. 2016; 68(1):54-61. DOI: 10.1161/HYPERTENSIONAHA.116.07201. View

20.

Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O . Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res. 2003; 26(10):771-82. DOI: 10.1291/hypres.26.771. View